Key result
Multidisciplinary care and novel targeted therapies remain essential to improve outcomes in pregnant PH patients.
Why the study?
Pulmonary hypertension in pregnancy carries high maternal and fetal morbidity and mortality, while novel targeted therapies and multidisciplinary management strategies have evolved.
A multidisciplinary approach and novel targeted therapies are essential for improving outcomes in pregnant women with pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
May support individualized multidisciplinary care in pregnant PH patients; leaves open prospective validation of novel therapies.
Pulmonary hypertension in pregnancy carries a high maternal and fetal morbidity, and mortality. In recent times, there has been significant progress in the field of pulmonary vascular disease with a better understanding of the disease and novel targeted therapies, which have ultimately resulted in improved outcomes. In addition, the development of an individualized and multidisciplinary approach to the management of pulmonary hypertension during pregnancy is essential for improved outcomes.
No takes yet. Share an insight, caveat, or question.
Moni et al. (2020) conducted a review in Pulmonary hypertension in pregnancy. An individualized and multidisciplinary approach, alongside novel targeted therapies, is essential for improving outcomes in pregnant patients with pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: